Other Species / Isoforms
  TACE (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S26-p
RPPEEAGsGsHPRLE
0 1
TACE (human) RPPDDPGFGPHQRLE F26
TACE (mouse) RPPEEAGsGsHPRLE S26-p
TACE (rat) RPPEEPGSGSHLRLE S26
S28-p
PEEAGsGsHPRLEKL
0 1
TACE (human) PDDPGFGPHQRLEKL P28
TACE (mouse) PEEAGsGsHPRLEKL S28-p
TACE (rat) PEEPGSGSHLRLEKL S28
Y82
LKRHFKLYLTSSTER
0 1
TACE (human) LKRHFKLyLtSStER Y82-p
TACE (mouse) LKRHFKLYLTSSTER Y82
TACE (rat) LKRHFKLYLTSSTER Y82
T84
RHFKLYLTSSTERFS
0 1
TACE (human) RHFKLyLtSStERFS T84-p
TACE (mouse) RHFKLYLTSSTERFS T84
TACE (rat) RHFKLYLTSSTERFS T84
T87
KLYLTSSTERFSQNL
0 1
TACE (human) KLyLtSStERFSQNF T87-p
TACE (mouse) KLYLTSSTERFSQNL T87
TACE (rat) KLYLTSSTERFSQNL T87
K102
RVVVVDGKEESEYSV
0 1
TACE (human) KVVVVDGkNESEYTV K102-ub
TACE (mouse) RVVVVDGKEESEYSV K102
TACE (rat) RVVVVDGKEESEYSV K102
N157-ng
EPLWRFVnDTKDKRM
0 1
TACE (human) EPLWRFVNDTKDKRM N157
TACE (mouse) EPLWRFVnDTKDKRM N157-ng
TACE (rat) EPLWRFVNDTKDKRM N157
K168
DKRMLVYKSEDIKDF
0 1
TACE (human) DKRMLVYkSEDIKNV K168-ub
TACE (mouse) DKRMLVYKSEDIKDF K168
TACE (rat) DKRMLVYKSEDIKDF K168
K182
FSRLQSPKVCGYLNA
0 2
TACE (human) VSRLQSPkVCGYLKV K182-ub
TACE (mouse) FSRLQSPKVCGYLNA K182
TACE (rat) FSRLQSPKVCGYLNA K182
K197
DSEELLPKGLIDREP
0 1
TACE (human) DNEELLPkGLVDREP K197-ub
TACE (mouse) DSEELLPKGLIDREP K197
TACE (rat) DSEELLPKGLIDREP K197
N264-ng
RVDDIYRnTSWDNAG
0 1
TACE (human) RVDDIYRNTSWDNAG N264
TACE (mouse) RVDDIYRnTSWDNAG N264-ng
TACE (rat) RVDDIYRNTSWDNAG N264
K302
ERHFNMAKSFPNEEK
0 1
TACE (human) EKHYNMAkSYPNEEk K302-ub
TACE (mouse) ERHFNMAKSFPNEEK K302
TACE (rat) ERHFNMAKSFPNEEK K302
K309
KSFPNEEKDAWDVKM
0 1
TACE (human) kSYPNEEkDAWDVKM K309-ub
TACE (mouse) KSFPNEEKDAWDVKM K309
TACE (rat) KSFPNEEKDAWDVKM K309
K376
YYNPTVKKNIYLNSG
0 1
TACE (human) YYSPVGKkNIyLNsG K376-ub
TACE (mouse) YYNPTVKKNIYLNSG K376
TACE (rat) YYNPGVKKNIYLNSG K376
Y379
PTVKKNIYLNSGLTS
0 1
TACE (human) PVGKkNIyLNsGLTS Y379-p
TACE (mouse) PTVKKNIYLNSGLTS Y379
TACE (rat) PGVKKNIYLNSGLTS Y379
S382
KKNIYLNSGLTSTKN
0 1
TACE (human) KkNIyLNsGLTSTkN S382-p
TACE (mouse) KKNIYLNSGLTSTKN S382
TACE (rat) KKNIYLNSGLTSTKN S382
K388
NSGLTSTKNYGKTIL
0 1
TACE (human) NsGLTSTkNYGkTIL K388-ub
TACE (mouse) NSGLTSTKNYGKTIL K388
TACE (rat) NSGLTSTKNYGKTIL K388
K392
TSTKNYGKTILTKEA
0 1
TACE (human) TSTkNYGkTILTKEA K392-ub
TACE (mouse) TSTKNYGKTILTKEA K392
TACE (rat) TSTKNYGKTILTKEA K392
Y433
NEDQGGKYVMYPIAV
0 1
TACE (human) NEDQGGKyVMyPIAV Y433-p
TACE (mouse) NEDQGGKYVMYPIAV Y433
TACE (rat) NEDQGGKYVMYPIAV Y433
Y436
QGGKYVMYPIAVSGD
0 1
TACE (human) QGGKyVMyPIAVSGD Y436-p
TACE (mouse) QGGKYVMYPIAVSGD Y436
TACE (rat) QGGKYVMYPIAVSGD Y436
K460
CSKQSIYKTIESKAQ
0 1
TACE (human) CSKQSIYkTIESkAQ K460-ub
TACE (mouse) CSKQSIYKTIESKAQ K460
TACE (rat) CSKQSIYKTIESKAQ K460
K465
IYKTIESKAQECFQE
0 1
TACE (human) IYkTIESkAQECFQE K465-ub
TACE (mouse) IYKTIESKAQECFQE K465
TACE (rat) IYKTIESKAQECFQE K465
N539-ng
KKCQEAInATCKGVS
0 1
TACE (human) KKCQEAINATCKGVS N539
TACE (mouse) KKCQEAInATCKGVS N539-ng
TACE (rat) KKCQEAINATCKGVS N539
N551-ng
GVSYCTGnSSECPPP
0 1
TACE (human) GVSYCTGNSSECPPP N551
TACE (mouse) GVSYCTGnSSECPPP N551-ng
TACE (rat) GVSYCTGNSSECPPP N551
N606-ng
SCKVCCRnLSGPCVP
0 1
TACE (human) SCKVCCRDLSGRCVP D606
TACE (mouse) SCKVCCRnLSGPCVP N606-ng
TACE (rat) SCKVCCRNLSGPCVP N606
K620
PYVDAEQKNLFLRKG
0 1
TACE (human) PYVDAEQkNLFLRKG K620-ub
TACE (mouse) PYVDAEQKNLFLRKG K620
TACE (rat) PYVDAEQKNLFLRKG K620
Y702-p
DKKLDKQyESLSLFH
Upstream
Downstream
3 0
Effects on Modified Protein
  • activity, induced
  • intracellular localization
  • molecular association, regulation
Putative in vivo kinases:
  • Src (rat)
TACE (human) DKKLDKQYESLsLFH Y702
TACE (mouse) DKKLDKQyESLSLFH Y702-p
TACE (rat) DKKLDKQyESLSLFH Y702-p
S706
DKQyESLSLFHHSNI
0 1
TACE (human) DKQYESLsLFHPSNV S706-p
TACE (mouse) DKQyESLSLFHHSNI S706
TACE (rat) DKQyESLSLFHHSNI S706
K728-ub
SASVRIIkPFPAPQt
0 7
TACE (human) SASVRIIkPFPAPQt K728-ub
TACE (mouse) SASVRIIkPFPAPQt K728-ub
TACE (rat) SASVRIIKPFPAPQt K728
T735-p
kPFPAPQtPGRLQAL
Upstream
Downstream
18 17
Effects on Modified Protein
  • activity, induced
  • enzymatic activity, induced
  • intracellular localization
  • molecular association, regulation
Effects on Biological Processes:
  • carcinogenesis, induced
  • signaling pathway regulation
Kinase, in vitro:
  • ERK1 (human)
Putative in vivo kinases:
  • ERK1 (mouse)
Regulatory protein:
  • mAChR m1 (mouse)
Treatment
  • anisomycin
  • Astragaloside-III
  • carbachol
  • DPCPX
  • GF109203X
  • IL-1b
  • insulin
  • LY294002
  • Paeoniflorin
  • phorbol_ester
  • PP2
  • SB203580
  • SP600125
  • TAPI-0
TACE (human) kPFPAPQtPGRLQPA T735-p
TACE (mouse) kPFPAPQtPGRLQAL T735-p
TACE (rat) KPFPAPQtPGRLQAL T735-p
P750
QPAAMMPPVPAAPKL
0 1
TACE (human) QPAPVIPsAPAAPkL S747-p
TACE (mouse) QPAAMMPPVPAAPKL P750
TACE (rat) QPAAMMPPVSAAPKL P750
K756
PPVPAAPKLDHQRMD
0 3
TACE (human) PsAPAAPkLDHQRMD K753-ub
TACE (mouse) PPVPAAPKLDHQRMD K756
TACE (rat) PPVSAAPKLDHQRMD K756
T764-p
LDHQRMDtIQEDPst
0 12
TACE (human) LDHQRMDtIQEDPst T761-p
TACE (mouse) LDHQRMDtIQEDPst T764-p
TACE (rat) LDHQRMDTIQEDPst T764
S770-p
DtIQEDPstDsHADD
0 6
TACE (human) DtIQEDPstDsHMDE S767-p
TACE (mouse) DtIQEDPstDsHADD S770-p
TACE (rat) DTIQEDPstDsHVDD S770-p
T771-p
tIQEDPstDsHADDD
0 6
TACE (human) tIQEDPstDsHMDED T768-p
TACE (mouse) tIQEDPstDsHADDD T771-p
TACE (rat) TIQEDPstDsHVDDD T771-p
S773-p
QEDPstDsHADDDGF
Upstream
0 8
Treatment
  • insulin
TACE (human) QEDPstDsHMDEDGF S770-p
TACE (mouse) QEDPstDsHADDDGF S773-p
TACE (rat) QEDPstDsHVDDDGF S773-p
K782
ADDDGFEKDPFPNsS
0 1
TACE (human) MDEDGFEkDPFPNsS K779-ub
TACE (mouse) ADDDGFEKDPFPNsS K782
TACE (rat) VDDDGFEKDPFPNSS K782
S788-p
EKDPFPNsSTAAKsF
0 4
TACE (human) EkDPFPNsSTAAksF S785-p
TACE (mouse) EKDPFPNsSTAAKsF S788-p
TACE (rat) EKDPFPNSSAAAKsF S788
K793
PNsSTAAKsFEDLTD
0 3
TACE (human) PNsSTAAksFEDLtD K790-ub
TACE (mouse) PNsSTAAKsFEDLTD K793
TACE (rat) PNSSAAAKsFEDLTD K793
S794-p
NsSTAAKsFEDLTDH
Upstream
Downstream
4 54
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Putative in vivo kinases:
  • PLK2 (human)
Treatment
  • LPS
  • phorbol_ester
TACE (human) NsSTAAksFEDLtDH S791-p
TACE (mouse) NsSTAAKsFEDLTDH S794-p
TACE (rat) NSSAAAKsFEDLTDH S794-p
T799
AKsFEDLTDHPVTRS
0 1
TACE (human) AksFEDLtDHPVTRS T796-p
TACE (mouse) AKsFEDLTDHPVTRS T799
TACE (rat) AKsFEDLTDHPVTRS T799
K808
HPVTRSEKAAsFKLQ
0 1
TACE (human) HPVTRSEkAAsFkLQ K805-ub
TACE (mouse) HPVTRSEKAAsFKLQ K808
TACE (rat) HPVTRSEKAAsFKLQ K808
S811-p
TRSEKAAsFKLQRQS
2 3
TACE (human) TRSEkAAsFkLQRQN S808-p
TACE (mouse) TRSEKAAsFKLQRQS S811-p
TACE (rat) TRSEKAAsFKLQRQS S811-p
K813
SEKAAsFKLQRQSRV
0 1
TACE (human) SEkAAsFkLQRQNRV K810-ub
TACE (mouse) SEKAAsFKLQRQSRV K813
TACE (rat) SEKAAsFKLQRQSRV K813
S822-p
QRQSRVDsKETEC__
3 8
TACE (human) QRQNRVDsKETEC__ S819-p
TACE (mouse) QRQSRVDsKETEC__ S822-p
TACE (rat) QRQSRVDSKETEC__ S822